Condition
Dural Arteriovenous Fistula
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05028400Not ApplicableCompleted
Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery
NCT03317821CompletedPrimary
PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF
NCT03524976CompletedPrimary
Treatment of Dural Arteriovenous Fistulas With SQUID™ Liquid Embolic Agent
Showing all 3 trials